Skip to content

Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training for Incomplete Spinal Cord Injury Patients

Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training: a Potential Therapy for Incomplete Spinal Cord Injury Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02441179
Enrollment
35
Registered
2015-05-12
Start date
2015-03-31
Completion date
2015-10-31
Last updated
2016-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

acute intermittent hypoxia, rehabilitation, spinal cord injury

Brief summary

Spinal cord injury (SCI) interrupts descending synaptic pathways from brainstem premotor neurons to spinal motor neurons, thereby paralyzing muscles below the neurological level. In recent years, considerable evidence has demonstrated that acute intermittent hypoxia (AIH) elicits plasticity in the spinal cord and strengthens spare synaptic pathways which is expressed as respiratory and somatic functional recovery in animals and humans suffering from incomplete SCI. The fundamental hypothesis guiding this project is that AIH-induced motor plasticity can be harnessed to improve walking capacity in incomplete SCI patients, classified as C and D categories according to International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The inclusion criteria include patients \> 18 years-old, with traumatic or non-traumatic, non-progressive incomplete SCI, onset \> 6 months, neurological level C5-T12, with walking ability with or without assistive devices, without joint contractures, orthopedic injuries, osteoporosis, cutaneous lesions, cardiopulmonary complications and a body weight below 150 Kg. A randomized, triple-blind, placebo-controlled parallel design study will be done including 100% of patients fulfilling the criteria. Participants will receive repetitive acute intermittent hypoxia (rAIH: 15 episodes of 90 second 9% inspired oxygen interspersed with 90-second normoxia) or repetitive continued normoxia (rSham: 21% inspired oxygen) combined with 45 minutes body weight-supported treadmill training on 5 consecutive days and then three times per week for 3 weeks. Primary outcome measurement will be the 10-meter walking test. Secondary outcome measurements include the 6-minute walking test, timed up and go test, body/weight load, modified ashworth scale and visual analog scale. All outcomes will be measured before beginning the protocol (baseline), after five days of AIH/Sham (D5), weekly up to the end of the study (W2-W4), and a post-study follow-up for 2 weeks (F1-F2). Aditionally, cognitive assesment before and after the study will be performed using the Figura compleja de Rey-Osterrieth and the Test de aprendizaje verbal España Complutense (TAVEC). Repetitive AIH and body weight-supported treadmill training may represent a novel, safe, and noninvasive potential therapy to partially restore walking function in incomplete sub-acute and chronic SCI patients, a population with limited, if any, potential for improved function.

Detailed description

Currently, there is no cure for spinal cord injuries (SCI). Although the scientific understanding of central nervous system (CNS) regeneration has advanced greatly in the past twenty years, there are still many unknowns with regard to inducing successful regeneration, especially with chronic SCI. A more realistic approach, based on currently available knowledge, to improve the quality of life for a large proportion of the paralyzed population may be to develop treatments that elicit partial functional recovery based on neuroplastic potential of spared neural pathways. In this scenario, acute intermittent hypoxia (AIH) enhances the inherit capacity for neuroplasticity and strengthens surviving synaptic inputs onto spinal motorneurons, which trigger functional recovery following SCI in rats and humans AIH-induced neuroplasticity has been extensively studied in phrenic motor nuclei (C3-C5) through phrenic nerve recording preparations (Mitchell, 2007). Briefly, moderate AIH (3, 5-min hypoxic episodes; PaO2 35-45 mmHg; 5-min intervals) elicits phrenic long term facilitation (pLTF), a type of memory present in the cervical spinal cord. The mechanism of AIH-induced pLTF is that episodic hypoxia activates raphe serotonergic neurons that project to phrenic motor nuclei. Spinal serotonin release during hypoxic episodes subsequently activates serotonin type 2 (5-HT2) receptors coupled to Gq protein on or near phrenic motor neurons, and initiates intracellular cascades that underlie pLTF . pLTF requires spinal 5-HT2 receptor activation , new synthesis of brain-derived neurotrophic factor (BDNF) and activation of its high-affinity receptor tyrosine kinase (TrkB) followed by ERK MAP kinase signaling. Although downstream signaling events from ERK are less clear, it is speculated that glutamate receptors are phosphorylated, increasing glutamatergic transmission and perhaps insertion within phrenic motor neurons, thereby establishing LTF. Longer time domains of AIH, for example, daily acute intermittent hypoxia (i.e. dAIH, 10 episodes per day, 7 days) have shown to strengthen synaptic pathways to spinal motorneurons and increase respiratory and locomotor recovery after cervical SCI in unanesthetized rats. This functional improvement is accompanied by increased BDNF and TrkB levels within cervical (C7) motor nuclei innervating the forelimb. Although the detailed mechanisms of the functional recovery in somatic thoracic or lumbar motorneurons have not been verified, it has been proposed that the same serotonin-dependent mechanisms facilitate motor output in respiratory and non-respiratory motor nuclei. The use of dAIH to improve limb function in humans with incomplete, chronic SCI has shown promising results. A single presentation of AIH (15, 1-minute episodes of 9% O2 alternating with 1-minute of 21% O2) in incomplete, chronic (\>1 year) spinal cord injury patients, classified as C or D according to the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), increases the ability to voluntarily generate plantar flexion 4 h post-hypoxia. In a randomized, double-blind, placebo-controlled, crossover design study, the impact of daily AIH (15 episodes per day, 90 sec 9% O2, 60 sec normoxic interval, 5 consecutive days) combined with walking training was studied in 19 chronic, incomplete SCI patients (ISNCSCI D). Daily AIH alone increased walking speed 18% three days after treatment (10 m walk test); whereas dAIH combined with walking training improved both walking speed and distance (37%) after 5 days and 1 week post-dAIH. Importantly, no changes in cognitive function was observed after dAIH, suggesting that this moderate dose of AIH is safe in humans. Although dAIH (5 consecutive days of AIH) has demonstrated beneficial effects in incomplete SCI patients, its effect last only up to one week; therefore, is important to design extended protocols maintaining the initial functional effect of dAIH over time. Repetitive AIH (rAIH) consisting of AIH three times per week (3×wAIH) for 10 weeks have demonstrated to increase respiratory function and maintain the increased functional effect elicited by dAIH in unanesthetized rats. Moreover, rAIH increases the expression of key molecules involved in AIH-induced spinal plasticity in unanesthetized rats. Therefore, repetitive AIH may represent a safe and effective strategy to enhance functional recovery after chronic incomplete spinal cord injuries. The protocol of intermittent hypoxia proposed in this project corresponds to a moderate dose of intermittent hypoxia, which is the equivalent of climbing a mountain at 5000 meters altitude. Abundant literature has demonstrated that moderate AIH (≥ 9% O2, \< 15 cycles/day) have several multi-systemic beneficial effects: reduces arterial hypertension, strengthens innate immune responses, reduces inflammation, reduces body weight, increases aerobic capacity, improves glucose tolerance, increases bone mineral density, enhances spatial learning and memory, rescues ischemia-induced memory impairment, reduces symptoms of depression, improves post-ischemic recovery of myocardial contractile function, and increases respiratory capacity in chronic obstructive pulmonary disease. Moreover, moderate repetitive AIH improves respiratory and somatic function after SCI, without adverse consequences such as hypertension, neuronal cell loss and/or reactive gliosis or systemic inflammation. Therefore, the potential beneficial effects of AIH are not only limited to spinal cord injuries but include a wide scope of clinical conditions. Combinatorial therapies, one of them being an activity-based training, can augment plasticity after incomplete SCI. In rats with incomplete SCI, dAIH combined with ladder walking leads to near complete recovery of ladder walking ability. Moreover, dAIH and overground walking improve walking speed and distance in incomplete SCI patients ISNCSCI D. Research studies in animals and humans have found that retraining after SCI using the intrinsic physiologic properties of the nervous system can facilitate the recovery of function. This potential for retraining is based on activity-dependent plasticity driven by repetitive task-specific sensory input to spinal networks. The most prominent and well-developed activity-based therapy (physical rehabilitation) to date is locomotor training. The fundamental principles of locomotor training are built on the premise of robustly approximating the sensorimotor experience of walking through repetitive practice including: 1) maximize load bearing by the lower extremities and minimize load bearing by the upper extremities, 2) optimize the sensory cues for walking, 3) optimize the kinematics (i.e., trunk and extremities) for each motor task, and 4) maximize recovery strategies and minimize compensatory mechanisms. The fundamental mechanisms supporting this intervention have been derived largely from studies conducted in spinalised animals. Specifically, treadmill training increases axonal regrowth and collateral sprouting proximal to the lesion site in mice (Goldshmit et al., 2008), phosphorylation of Erk1/2 in the motor cortex as well as the spinal cord injury area (Oh et al., 2009), expression of brain-derived neurotrophic factor (BDNF) in the spinal cord, ameliorates muscle atrophy in moderate contused SCI rats, and alters properties of spinal motor neurons. Body weight-supported treadmill training (BWSTT) is based on optimizing sensory inputs relevant to step training, repeated practice, and possible optimization of neuroplasticity. Uncontrolled studies in acute and chronic SCI patients show within-subject improvements in walking ability using BWSTT. Investigators propose that BWSTT therapy provide a behavioral therapy that independently supports positive outcomes. AIH combined with body weight-assisted training represents a simple and safe, non-pharmacological method for enhancing neuroplasticity in the spinal cord and thus, improving walking function in patients with incomplete spinal cord injuries. At the cellular level, both BWSTT and AIH increase the expression of BDNF. BDNF has a wide repertoire of neurotrophic and neuroprotective properties in the CNS and the periphery; namely, neuronal protection and survival, neurite expression, axonal and dendritic growth and remodeling, neuronal differentiation and synaptic plasticity such as synaptogenesis in arborizing axon terminals, and synaptic transmission efficacy. Thus, BWSTT may serve as a catalyst in tandem with repetitive AIH that when combined develop an even better response. Currently, there are no approved therapies for chronic SCI; therefore, the approach represents a promising new strategy to enhance function in patients with sub-acute and chronic SCI, where the potential for further functional gains is limited. Investigators propose a triple blind (patients, outcome assessors and stadistician) randomized, placebo-controlled study testing the combined effect of intermittent hipoxia and body weight-supported treadmill training in incoplete spinal cord injury patients.

Interventions

Patients will breath 9% oxigen for 1.5 minutes interspersed with 1.5 minutes of 21% oxigen (normoxia), 15 times for a total of 45 minutes.

OTHERBody weight-assisted treadmill training

Patient´s gait will be trained through a weight-assisted treadmill (BWSTT). All recruited patients will start BWSTT at a speed of 0.6 km/hr. The physical therapist will manually correct posture to assure an adequate gait, increasing the speed of treadmill progressively depending upon the patient progress and tolerance. This training will be done immediately after the protocol of AIH or Sham and it will last 45 minutes.

It consists of continuous normoxia (FiO2=0.21) for 45 minutes for 5 consecutive days and then 3 times per week for 3 weeks. Total time: 4 weeks.

Sponsors

Hospital Clinico Mutual de Seguridad
CollaboratorOTHER
Sociedad Pro Ayuda del Niño Lisiado
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients ≥ 18 years-old from Instituto Teletón Santiago and Hospital Clínico Mutual de seguridad. 2. C5 to T12 spinal cord injury, classified as ISNCSCI grades C and D 3. Traumatic and non-traumatic, non-progressive lesions 4. Onset \> 6 months 5. Ability to ambulate with or without assistive devices 6. Ability to follow verbal or visual commands 7. Signed informed consent

Exclusion criteria

1. Orthopedic injuries that are unstable 2. Osteoporosis with high risk of pathological fracture 3. Cutaneous lesions and/or pressure ulcers 4. Joint contractures 5. Cardiopulmonary diseases 6. Body weight exceeding 150 Kg

Design outcomes

Primary

MeasureTime frameDescription
Gait Speed With 10-Meter Walk TestChange from baseline in gait speed five days after daily IH.The 10-meter walk test measures the time (in seconds) that it takes a patient to walk 10m.

Secondary

MeasureTime frameDescription
Gait Speed With the Timed up and go TestChange from baseline in gait speed five days after daily IH.The timed up and go test measures the time (in seconds) it takes the patient to stand-up from a seated position in a chair, walk 3 meters at a comfortable and safe pace, turn, walk back to the chair and sit down.
Percentage of Subjects With Worsening Muscle Tone on the Ashworth ScaleMuscle tone at week 4.The Ashworth Scale assess muscle tone. It is a 5-points scale ranging from 0 (no increase in muscle tone) to 4 (limb rigid in flexion or extension).
Gait Endurance With the 6-Minute Walk TestChange from baseline in gait indurance five days after daily IH.The 6-Minute Walk Test measures the distance (in meters) a patient is able to walk over 6 minutes.
Learning and Memory With the Rey-Osterrieth Complex Figure (ROCF) TestEpisodic visual memory at week 4.The ROCF is a neuropsychological instrument used for assessment of episodic visual memory. Z score ranges from -2 (worse outcome), -1, 0, 1 and 2 (best outcome). The normal population range is between -1 and 1. Z score was calculated with the following formula: Z score = (direct score-average for a particular age range)/standard deviation
Learning and Memory With the Complutense Verbal Learning Test (TAVEC)Episodic verbal memory at week 4.The TAVEC is the Spanish version of the California Verbal Learning Test and is used for the assessment of episodic verbal memory. Z score ranges from -2 (worse outcome), -1, 0, 1 and 2 (best outcome). The normal population range is between -1 and 1. Z score was calculated with the following formula: Z score = (direct score-average for a particular age range)/standard deviation
Percentage of Subjects With Worsening Pain Perception on the The Visual Analog TestPain perception at week 4The visual analog test assess general pain intensity. It is a 10-score scale ranging from no pain (score 0) to unbearable pain (score 10).

Countries

Chile

Participant flow

Recruitment details

67 eligible subjects from 4 hospitals were contacted for screening on site: Hospital Mutual de seguridad, Instituto Teletón, Clínica los Coihues and Hospital del Trabajador.Only 38 accepted the invitation. The main reason subjects reported to not participate was a tight working schedule and/or lack of employer's permission.

Pre-assignment details

Out of 38 eligible subjects, three were excluded due to brain trauma history and unknown cognitive deficits.Thus, 35 subjects were enrolled and randomly assigned to the arms.

Participants by arm

ArmCount
Intermittent Hypoxia Arm
IH protocol: it consists of 15, 90-second hypoxic episodes (FiO2=0.09) interspersed with 15, 90-second normoxic intervals (FiO2=0.21) for a total time of 45 minutes. This protocol was repeated every day for 5 consecutive days and then 3 times per week for 3 weeks. After each session of IH, patients received body weight-assisted treadmill training (BWSTT) for 45 minutes. BWSTT: Patient´s gait was trained through a weight-assisted treadmill (BWSTT). All recruited patients started BWSTT at a speed of 0.6 km/hr. The physical therapist manually corrected posture to assure an adequate gait, increasing the speed of treadmill progressively depending upon the patient progress and tolerance. This training was done immediately after the protocol of IH.
17
Normoxia Arm
Sham protocol: it consisted of continuous normoxia (FiO2=0.21) for 45 minutes for 5 consecutive days and then 3 times per week for 3 weeks. After each session, patients received body weight-assisted treadmill training (BWSTT) for 45 minutes. BWSTT: Patient´s gait was trained through a weight-assisted treadmill. All recruited patients started BWSTT at a speed of 0.6 km/hr. The physical therapist manually corrected the patient´s posture to assure an adequate gait, increasing the speed of treadmill progressively depending upon the patient progress and tolerance.
16
Total33

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicIntermittent Hypoxia ArmNormoxia ArmTotal
Age, Continuous41 years
STANDARD_DEVIATION 17
42 years
STANDARD_DEVIATION 17
41 years
STANDARD_DEVIATION 17
Region of Enrollment
Chile
17 participants16 participants33 participants
Sex: Female, Male
Female
2 Participants2 Participants4 Participants
Sex: Female, Male
Male
15 Participants14 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 180 / 17
serious
Total, serious adverse events
0 / 180 / 17

Outcome results

Primary

Gait Speed With 10-Meter Walk Test

The 10-meter walk test measures the time (in seconds) that it takes a patient to walk 10m.

Time frame: Change from baseline in gait speed five days after daily IH.

Population: Analysis was per protocol

ArmMeasureValue (MEAN)Dispersion
Intermittent Hypoxia ArmGait Speed With 10-Meter Walk Test-10.24 secondsStandard Error 3
Normoxia ArmGait Speed With 10-Meter Walk Test-1.79 secondsStandard Error 1.75
p-value: 0.006Kruskal-Wallis
Secondary

Gait Endurance With the 6-Minute Walk Test

The 6-Minute Walk Test measures the distance (in meters) a patient is able to walk over 6 minutes.

Time frame: Change from baseline in gait indurance five days after daily IH.

Population: The analysis was per protocol

ArmMeasureValue (MEAN)Dispersion
Intermittent Hypoxia ArmGait Endurance With the 6-Minute Walk Test43.06 metersStandard Error 10.68
Normoxia ArmGait Endurance With the 6-Minute Walk Test6.13 metersStandard Error 3.41
p-value: 0.012Kruskal-Wallis
Secondary

Gait Speed With the Timed up and go Test

The timed up and go test measures the time (in seconds) it takes the patient to stand-up from a seated position in a chair, walk 3 meters at a comfortable and safe pace, turn, walk back to the chair and sit down.

Time frame: Change from baseline in gait speed five days after daily IH.

Population: The analysis was per protocol

ArmMeasureValue (MEAN)Dispersion
Intermittent Hypoxia ArmGait Speed With the Timed up and go Test-8.71 secondsStandard Error 3.72
Normoxia ArmGait Speed With the Timed up and go Test-2.44 secondsStandard Error 2.28
p-value: 0.16Kruskal-Wallis
Secondary

Learning and Memory With the Complutense Verbal Learning Test (TAVEC)

The TAVEC is the Spanish version of the California Verbal Learning Test and is used for the assessment of episodic verbal memory. Z score ranges from -2 (worse outcome), -1, 0, 1 and 2 (best outcome). The normal population range is between -1 and 1. Z score was calculated with the following formula: Z score = (direct score-average for a particular age range)/standard deviation

Time frame: Episodic verbal memory at week 4.

Population: Analysis per protocol

ArmMeasureValue (MEDIAN)
Intermittent Hypoxia ArmLearning and Memory With the Complutense Verbal Learning Test (TAVEC)0 Z scores
Normoxia ArmLearning and Memory With the Complutense Verbal Learning Test (TAVEC)0 Z scores
p-value: 0.55Wilcoxon (Mann-Whitney)
Secondary

Learning and Memory With the Rey-Osterrieth Complex Figure (ROCF) Test

The ROCF is a neuropsychological instrument used for assessment of episodic visual memory. Z score ranges from -2 (worse outcome), -1, 0, 1 and 2 (best outcome). The normal population range is between -1 and 1. Z score was calculated with the following formula: Z score = (direct score-average for a particular age range)/standard deviation

Time frame: Episodic visual memory at week 4.

Population: Analysis per protocol

ArmMeasureValue (MEDIAN)
Intermittent Hypoxia ArmLearning and Memory With the Rey-Osterrieth Complex Figure (ROCF) Test0.19 Z scores
Normoxia ArmLearning and Memory With the Rey-Osterrieth Complex Figure (ROCF) Test0.16 Z scores
p-value: 0.43Wilcoxon (Mann-Whitney)
Secondary

Percentage of Subjects With Worsening Muscle Tone on the Ashworth Scale

The Ashworth Scale assess muscle tone. It is a 5-points scale ranging from 0 (no increase in muscle tone) to 4 (limb rigid in flexion or extension).

Time frame: Muscle tone at week 4.

Population: Analysis per protocol

ArmMeasureValue (NUMBER)
Intermittent Hypoxia ArmPercentage of Subjects With Worsening Muscle Tone on the Ashworth Scale24 percentage of subjects
Normoxia ArmPercentage of Subjects With Worsening Muscle Tone on the Ashworth Scale31 percentage of subjects
p-value: 0.57Chi-squared
Secondary

Percentage of Subjects With Worsening Pain Perception on the The Visual Analog Test

The visual analog test assess general pain intensity. It is a 10-score scale ranging from no pain (score 0) to unbearable pain (score 10).

Time frame: Pain perception at week 4

Population: Analysis per protocol

ArmMeasureValue (NUMBER)
Intermittent Hypoxia ArmPercentage of Subjects With Worsening Pain Perception on the The Visual Analog Test11 percentage of subjects
Normoxia ArmPercentage of Subjects With Worsening Pain Perception on the The Visual Analog Test25 percentage of subjects
p-value: 0.14Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026